Brief: NextCure And LegoChem Biosciences Enter Into Collaboration
15/11/2022 22:13
Nov 15 (Reuters) - LegoChem Biosciences Inc 141080.KQ :
* NEXTCURE AND LEGOCHEM BIOSCIENCES ENTER INTO COLLABORATION
AND
CO-DEVELOPMENT AGREEMENT TO DEVELOP ANTIBODY DRUG CONJUGATES
Source text for Eikon: ID:nGNX2nWm8X
Further company coverage: 141080.KQ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NextCure
See all newsBrief: Xcellon Biologics Co Acquires Gmp Manufacturing Facility From Nextcure
NextCure Inc reports results for the quarter ended June 30 - Earnings Summary
NextCure Q2 net loss narrows on lower expenses
Brief: NextCure Q2 Net Income USD -14.892 Million
NextCure Inc expected to post a loss of $1.93 a share - Earnings Preview